Dynamic heterogeneity in COVID-19: Insights from a mathematical model.

Area of Science:

• Infectious Disease Modeling
• Computational Biology
• Immunology

Background:

• Critical illnesses like severe COVID-19 exhibit heterogeneous clinical presentations and treatment responses.
• Individual patient trajectories can diverge due to dynamic, random, or external factors despite similar initial injuries.

Purpose of the Study:

• To employ a mechanistic mathematical model to explore the spectrum of clinical courses following SARS-CoV-2 infection.
• To investigate how variations in viral properties, immune responses, treatment, and external factors influence disease progression.

Main Methods:

• Development and deployment of a mechanistic mathematical model simulating COVID-19.
• Analysis of potential clinical trajectories based on modifications to viral and immune properties, treatment strategies, and initial viral load.

Main Results:

• Treatment efficacy and baseline patient/viral characteristics are insufficient to solely predict outcomes.
• Enhanced immune responses do not guarantee viral control, with outcomes varying based on treatment and initial viral load.
• Hypoxemia can arise from poor viral control or inflammation, even with effective viral clearance.
• Early effective therapy may suppress adaptive immunity, leading to viral rebound post-treatment.

Conclusions:

• The course of severe COVID-19 is shaped by complex interactions between external factors and patient-intrinsic elements.
• Findings impact the understanding of clinical trial cohort reproducibility and optimal treatment timing.